Clinical Trial Update: Gefitinib in Treating Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating gefitinib in patients with cervical cancer and related gynecologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED